Newsroom
Truveta news releases
Truveta outlines a path toward a continuously learning healthcare system in new peer-reviewed publication
New JAMIA Open paper describes how health systems, artificial intelligence, and continuously updated clinical data can transform routine care into living evidence BELLEVUE, Wash., August 6, 2026—Truveta announced the publication of a new peer-reviewed paper in JAMIA...
Truveta Language Model unlocks research-ready cancer staging data from millions of clinical notes
Published in JCO Clinical Cancer Informatics, new Truveta research demonstrates scalable, high-precision extraction of critical cancer staging information BELLEVUE, Wash.—July 28, 2026—Truveta recently published a peer-reviewed study in JCO Clinical Cancer Informatics...
New study finds GLP-1 receptor agonists associated with lower risk of alcohol-related hospitalization among adults with alcohol use disorder
Large multi-system study using target trial emulation found consistent associations across patients with alcohol use disorder and either type 2 diabetes or obesity BELLEVUE, Wash.—July 21, 2026—Researchers from Truveta, Johns Hopkins Bloomberg School of Public Health,...
New study examines real-world switching patterns after patients transition from Humira to biosimilars
Analysis of nearly 68,000 patients finds biosimilar adoption increased following formulary changes; however, more than 1 in 7 patients switch back to Humira BELLEVUE, Wash.—June 29, 2026—Researchers from Truveta have found that adoption of adalimumab biosimilars...
New study finds Shingrix vaccination rates rising rapidly among newly eligible adults, but disparities remain
Analysis of nearly 154,000 adults identifies key factors associated with shingles vaccine uptake and completion BELLEVUE, Wash.—June 18, 2026—Researchers from Truveta have found that uptake of the shingles vaccine Shingrix has increased substantially among adults...
New study reveals major gaps in follow-up care for patients with heart failure
Most patients with newly identified heart failure did not receive repeat heart function assessment, despite guideline recommendations BELLEVUE, Wash.—May 21, 2026—A new peer-reviewed study led by Truveta and collaborators at Yale School of Medicine, Yale New Haven...
Truveta and Knit Health announce collaboration to power a new generation of clinical AI
Combining one of the nation’s most comprehensive real-world clinical datasets with next-generation behavioral AI models to transform care delivery and patient outcomes BELLEVUE, Wash. and SAN FRANCISCO, Calif.—May 12, 2026—Truveta and Knit Health today announced a...
Truveta unveils Truveta Intelligence, delivering real-time insights from real-world data
New AI-powered experience removes the time-to-evidence barrier, enabling healthcare leaders to better understand and make informed decisions based on what’s happening in care today BELLEVUE, Wash.—April 28, 2026— Truveta today announced Truveta Intelligence, a new...
Truveta deepens health system leadership with appointment of Erik Wexler to Board of Directors
Providence President and CEO brings extensive experience advancing innovation, operations, and patient-centered care at scale. BELLEVUE, Wash.— March 31, 2026—Grounded in its mission of Saving Lives with Data, Truveta today announced the appointment of Erik Wexler,...
